CFDB - Cystic Fibrosis DataBase

at least one term
all terms
All subcategories » published RCT

The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.

primary studies  published RCT

Details
  • 2005
  • Blumer JL

Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.

primary studies  published RCT

Details
  • 2005
  • Cimmino M

Physiologic evidence for high-frequency chest wall oscillation and positive expiratory pressure breathing in hospitalized subjects with cystic fibrosis.

primary studies  published RCT

Details
  • 2005
  • Darbee JC

Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis.

primary studies  published RCT

Details
  • 2005
  • Deterding R

Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis.

primary studies  published RCT

Details
  • 2005
  • Dodd JD

Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!.

primary studies  published RCT

Details
  • 2005
  • Farrell PM

A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.

primary studies  published RCT

Details
  • 2005
  • Fitzgerald DA

Short-term protein intake and stimulation of protein synthesis in stunted children with cystic fibrosis.

primary studies  published RCT

Details
  • 2005
  • Geukers VG

Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study.

primary studies  published RCT

Details
  • 2005
  • Grasemann H

Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients.

primary studies  published RCT

Details
  • 2005
  • Griese M